ESR1 and breast cancer: A correlation between DTI parameters and molecular prognostic factors (estrogen receptor status or Ki-67) has been shown (49) and DTI has been investigated to differentiate recurrent breast cancer from post operative changes with breast-conserving surgery in patients (85).